RACHEL JOSEFCHUK: Open Payments
NPI 1215580469 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 12 payments from 6 companies in 2025. Trend: 2023 $346 · 2024 $90 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $176 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| Alkermes, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, COBENFY, UZEDY.
Industry payments across AZ — which companies pay providers there.
